(Q42941908)

11 November 2017

Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir (English)

1 reference

11 November 2017

1 reference

1 reference

Mikko Neuvonen

4

0 references

Pertti J. Neuvonen

object named as

Pertti J Neuvonen

5

0 references

Nora Hagelberg

2

object named as

Nora M Hagelberg

1 reference

11 November 2017

Tuija H Nieminen

1

1 reference

11 November 2017

Teijo I Saari

3

1 reference

11 November 2017

Kari Laine

6

1 reference

11 November 2017

Klaus T Olkkola

7

1 reference

11 November 2017

10 August 2010

1 reference

European Journal of Clinical Pharmacology

11 November 2017

1 reference

11 November 2017

66

1 reference

11 November 2017

10

1 reference

11 November 2017

977-985

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-010-0879-1

11 November 2017

0 references

cites work

The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-010-0879-1

Pencil and paper tests-sensitivity to psychotropic drugs

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-010-0879-1

Mechanism-based inactivation of CYP3A by HIV protease inhibitors

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-010-0879-1

Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history

21 January 2018

1 reference

12 December 2020

Determination of oxycodone, noroxycodone, oxymorphone, and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometry

1 reference

12 December 2020

A novel LC-ESI-MS method for the simultaneous determination of etravirine, darunavir and ritonavir in human blood plasma

1 reference

12 December 2020

Measurement of Recovery from Outpatient General Anaesthesia with a Simple Ocular Test

1 reference

12 December 2020

Alprazolam-ritonavir interaction: implications for product labeling

1 reference

12 December 2020

Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone

1 reference

12 December 2020

HIV-associated neuropathic pain: epidemiology, pathophysiology and management

1 reference

12 December 2020

Rheumatic conditions in human immunodeficiency virus infection

1 reference

12 December 2020

Ritonavir's role in reducing fentanyl clearance and prolonging its half-life.

1 reference

12 December 2020

Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers.

1 reference

12 December 2020

Lopinavir/ritonavir reduces lamotrigine plasma concentrations in healthy subjects

1 reference

12 December 2020

Morphine and ibuprofen compared using the cold pressor test

1 reference

12 December 2020

Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: II. Ritonavir effects on CYP3A and P-glycoprotein activities

1 reference

12 December 2020

Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone

1 reference

12 December 2020

Cerebral kinetics of oxycodone in conscious sheep.

1 reference

12 December 2020

Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone

1 reference

12 December 2020

Steady-state pharmacokinetic and safety profiles of voriconazole and ritonavir in healthy male subjects

1 reference

12 December 2020

Apparent mechanism-based inhibition of human CYP3A in-vitro by lopinavir

1 reference

12 December 2020

Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesia

1 reference

12 December 2020

Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes.

1 reference

12 December 2020

Oxycodone induces overexpression of P-glycoprotein (ABCB1) and affects paclitaxel's tissue distribution in Sprague Dawley rats

1 reference

12 December 2020

Lopinavir/ritonavir: a review of its use in the management of HIV infection

1 reference

12 December 2020

1 reference

12 December 2020

Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone

1 reference

12 December 2020

CYP2D6 genotyping by a multiplex primer extension reaction.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites

1 reference

12 December 2020

Rapid clinical induction of hepatic cytochrome P4502B6 activity by ritonavir

1 reference

12 December 2020

Pain and pain treatment in AIDS patients: a longitudinal study.

1 reference

12 December 2020

The HIV-1 protease as a therapeutic target for AIDS

1 reference

12 December 2020

Pain in women with HIV/AIDS.

1 reference

12 December 2020

Diagnosis and management of neuropathic pain.

1 reference

12 December 2020

Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes

1 reference

12 December 2020

In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics.

1 reference

12 December 2020

Pharmacokinetic interaction between ritonavir and clarithromycin

1 reference

12 December 2020

Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833.

1 reference

12 December 2020

Differential inhibition of cytochrome P450 3A4, 3A5 and 3A7 by five human immunodeficiency virus (HIV) protease inhibitors in vitro

1 reference

12 December 2020

Symptom experience in HIV-infected adults: a function of demographic and clinical characteristics

1 reference

12 December 2020

Methadone pharmacokinetics are independent of cytochrome P4503A (CYP3A) activity and gastrointestinal drug transport: insights from methadone interactions with ritonavir/indinavir

1 reference

12 December 2020

Effect of telithromycin on the pharmacokinetics and pharmacodynamics of oral oxycodone

1 reference

12 December 2020

Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers

1 reference

12 December 2020

Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients

1 reference

12 December 2020

Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents

1 reference

12 December 2020

Voriconazole drastically increases exposure to oral oxycodone

1 reference

12 December 2020

Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects

1 reference

12 December 2020

10.1007/S00228-010-0879-1

Identifiers

DOI

1 reference

release_ifpdw2ji55dpdemgm6avxvcb6q

11 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ifpdw2ji55dpdemgm6avxvcb6q

24 November 2022

mapped directly with Wikidata item

1 reference